日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Phase 2 Trial of RANKL Antibody, Denosumab, in Two Cohorts of Patients with Recurrent/Refractory Osteosarcoma, a Report from the Children's Oncology Group

儿童肿瘤协作组报告:RANKL抗体地诺单抗治疗复发/难治性骨肉瘤两组患者的II期临床试验

Janeway, Katherine A; Chou, Alexander J; Buxton, Allen; Reid, Joel; Isakoff, Michael S; Kopp, Lisa; Hingorani, Pooja; Lee, Jill L; Doski, John; Daldrup-Link, Heike; Hall, Laura; Randall, R Lor; Reed, Damon R; Dubois, Steven G; Krailo, Mark; Grier, Holcombe; Gorlick, Richard

Collecting Social Determinants of Health in a Children's Oncology Group Trial for High-Risk Neuroblastoma

在儿童肿瘤协作组针对高危神经母细胞瘤的试验中收集健康社会决定因素

Jones, Emily; Naranjo, Arlene; Winestone, Lena E; Umaretiya, Puja J; Aziz-Bose, Rahela; Kelly, Colleen A; Newman, Haley; Zheng, Daniel J; Greengard, Emily; Bagatell, Rochelle; DuBois, Steven G; Bona, Kira

A pilot study of chemoimmunotherapy in the postconsolidation setting for high-risk neuroblastoma (ANBL19P1): A report from the Children's Oncology Group

一项针对高危神经母细胞瘤巩固治疗后化疗免疫疗法的试点研究(ANBL19P1):来自儿童肿瘤协作组的报告

Desai, Ami V; Naranjo, Arlene; LaBarre, Brian; Chen, Lulu; Goldsmith, Kelly C; Granger, Meaghan P; States, Lisa; Green, Sean G; Trunzo, Mariel; Fitzgerald, Wendy; DuBois, Steven G; Bagatell, Rochelle; Park, Julie R; Marachelian, Araz

Characterization of Clinical Outcomes for Patients with Relapsed High-Risk Neuroblastoma After Autologous Stem Cell Transplant and External Beam Radiotherapy

自体干细胞移植和体外放射治疗后复发性高危神经母细胞瘤患者的临床结局特征

Lin, Mathew; Chen, Jie Jane; Bagatell, Rochelle; Shaaban, Sherif G; Lerman, Benjamin J; Shusterman, Suzanne; Ioakeim-Ioannidou, Myrsini; Yock, Torunn I; Catalano, Paul J; Elhalawani, Hesham; Dusenbery, Kathryn E; Vo, Kieuhoa T; Huang, Mary S; Friedmann, Alison M; Diller, Lisa R; Marcus, Karen J; MacDonald, Shannon M; Terezakis, Stephanie A; Braunstein, Steve E; Hill-Kayser, Christine E; Haas-Kogan, Daphne A; DuBois, Steven G; Liu, Kevin X

Simplified dosimetry using two-time-point kinetic modeling of (124)I-MIBG PET for (131)I-MIBG therapy in neuroblastoma

利用 (124)I-MIBG PET 的双时间点动力学模型简化剂量测定,用于神经母细胞瘤的 (131)I-MIBG 治疗

Wang, Yiran; Huh, Yoonsuk; Matthay, Katherine K; Vo, Kieuhoa T; Pampaloni, Miguel H; DuBois, Steven G; Seo, Youngho

Leveraging Large Language Models to Extract Prognostic Pathology Features in Ewing Sarcoma

利用大型语言模型提取尤文氏肉瘤的预后病理特征

Huang, Jingwei; Batool, Ayesha; Gu, Zifan; Zhao, Zhuo; Yao, Bo; Black, Jennifer; Davis, Jessica; Al-Ibraheemi, Alyaa; DuBois, Steven; Barkauskas, Don; Ramakrishnan, Subhash; Hall, David; Grohar, Patrick; Xie, Yang; Xiao, Guanghua; Leavey, Patrick J

Hiding in plain sight: NUT carcinoma is an unrecognized subtype of squamous cell carcinoma of the lungs and head and neck

隐藏在眼皮底下:NUT癌是肺和头颈部鳞状细胞癌的一种未被充分认识的亚型。

Luo, Jia; Bishop, Justin A; DuBois, Steven G; Hanna, Glenn J; Sholl, Lynette M; Stelow, Edward B; Thompson, Lester D R; Shapiro, Geoffrey I; French, Christopher A

Molecular Characterization Informs Prognosis in Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group

分子特征分析有助于预测局限性尤文氏肉瘤患者的预后:来自儿童肿瘤协作组的报告

Gillani, Riaz; Shulman, David S; DelRocco, Natalie J; Klega, Kelly; Han, Ruxu; Krailo, Mark D; Slack, Jonathan C; Tanhaemami, Mohammad; Ward, Abigail; Bainer, Victoria; Ricker, Cora; Sparks, Josee; Bailey, Kelly M; Reed, Damon R; DuBois, Steven G; Leavey, Patrick; Mascarenhas, Leo; Grohar, Patrick J; Church, Alanna J; Crompton, Brian D; Janeway, Katherine A

Frequency and Clinical Significance of Clonal and Subclonal Driver Mutations in High-Risk Neuroblastoma at Diagnosis: A Children's Oncology Group Study

儿童肿瘤协作组研究:高危神经母细胞瘤诊断时克隆和亚克隆驱动基因突变的频率和临床意义

Berko, Esther R; Naranjo, Arlene; Daniels, Alexander A; McNulty, Samantha N; Krytska, Kateryna; Druley, Todd; Zelley, Kirstin; Koneru, Balakrishna; Chen, Lulu; Polkosnik, Grace; Irwin, Meredith S; Bagatell, Rochelle; Maris, John M; Reynolds, C Patrick; DuBois, Steven G; Park, Julie R; Mossé, Yael P

Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors

对患有 TRK 融合肉瘤及相关间叶肿瘤的儿科患者选择性停用拉罗替尼

Mascarenhas, Leo; DuBois, Steven G; Albert, Catherine M; Bielack, Stefan; Orbach, Daniel; Federman, Noah; Geoerger, Birgit; Nagasubramanian, Ramamoorthy; Zhang, Yizhou; Chisholm, Julia; Gallego Melcon, Soledad; Goto, Hiroaki; Morgenstern, Daniel A; Owens, Cormac; Pappo, Alberto S; Perreault, Sébastien; Schulte, Johannes H; Shukla, Neerav; Zwaan, Christian Michel; Neu, Natascha; Bernard-Gauthier, Vadim; De La Cuesta, Esther; van Tilburg, Cornelis M; Laetsch, Theodore W